CARIBBEAN MICROPARTICLES CORPORATION – Trademark Portfolio
Entity Type: 03
CARIBBEAN MICROPARTICLES CORPORATION holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include SIMPLY CELLULAR. The owner is based in HATO REY, PR.
515 AVENUE HOSTAS
SUITE 2C
HATO REY, PR 00918
Showing of trademarks Trademarks
Trademark Classifications
CARIBBEAN MICROPARTICLES CORPORATION's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does CARIBBEAN MICROPARTICLES CORPORATION have?
CARIBBEAN MICROPARTICLES CORPORATION has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does CARIBBEAN MICROPARTICLES CORPORATION file in?
CARIBBEAN MICROPARTICLES CORPORATION files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are CARIBBEAN MICROPARTICLES CORPORATION's most well-known trademarks?
CARIBBEAN MICROPARTICLES CORPORATION's registered trademark portfolio includes well-known marks such as SIMPLY CELLULAR. These are among 1 currently registered trademark in the portfolio.
What is CARIBBEAN MICROPARTICLES CORPORATION's trademark registration success rate?
CARIBBEAN MICROPARTICLES CORPORATION has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.